RNS Number : 6868K
NatWest Markets N.V.
01 July 2026
 

NatWest Markets N.V.

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 26 June 2026 (the "Final Terms") for NatWest Markets N.V. ("NatWest Markets NV") for the €300,000,000 Floating Rate Senior Notes due 30 June 2028 (ISIN: XS3429326815) (the "Notes") issued under the €5,000,000,000 Euro Medium Term Note Programme of NatWest Markets N.V. (the "Programme"). 

The Final Terms contain the final terms of the Notes and must be read in conjunction with the prospectus dated 4 June 2026, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129.

A copy of the above Final Terms has been submitted to the AFM and will shortly be available for inspection at NatWest Market NV's website at https://investors.natwestgroup.com/fixed-income-investors/unsecured-securities-documentation/senior-unsecured.aspx.

 

For further information, please contact:

Vasilis Tsagris

NatWest Markets N.V. Treasurer

Tel: +31 204 642 699

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the information in the Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

Legal Entity Identifier:  X3CZP3CK64YBHON1LE12

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBUGDRUUGDGLB